Robert D. Pesek

Professor

University of Arkansas for Medical Sciences

faculty

Peds Pediatrics, College of Medicine

19 h-index 68 pubs 1,277 cited

Research Areas

Eosinophilic Esophagitis Child and Adolescent Health Immune Response and Inflammation Food composition and properties Diet and metabolism studies Immune Cell Function and Interaction Health and Medical Research Impacts

Links

Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Robert D. Pesek, MD, is an Assistant Professor in Pediatrics at the University of Arkansas for Medical Sciences (UAMS) and serves as the medical director for the Allergy and Eosinophilic Gastrointestinal Disorders Clinics at Arkansas Children's Hospital. His clinical and research activities focus on primary immunodeficiency, food allergies, and eosinophilic gastrointestinal disorders. Dr. Pesek's work has contributed to the development of consensus recommendations for eosinophilic gastrointestinal disease nomenclature and clinical severity indices for eosinophilic esophagitis.

His research has investigated therapeutic interventions for eosinophilic esophagitis, including the use of dupilumab in pediatric patients, and the development of core outcome sets for therapeutic studies. Dr. Pesek has also explored dietary management strategies for eosinophilic esophagitis and investigated tolerance development in infants with cow's milk allergy undergoing specific formula interventions. His publication record includes work on the development of practical guides for diet therapy and the characterization of antigen-specific T cells in individuals undergoing oral immunotherapy for food allergies.

Dr. Pesek's academic background includes a Bachelor of Science from the University of Arkansas at Fayetteville and a medical degree from UAMS. He completed his pediatric residency at Arkansas Children's Hospital and his Allergy/Immunology fellowship at the University of South Florida. He has authored or co-authored 68 publications, with an h-index of 19 and over 1,200 citations. He is an active member of several professional medical societies, including the American Academy of Allergy, Asthma, and Immunology.

Research Overview

Robbie Pesek, MD, is an Assistant Professor of Allergy and Immunology for the University of Arkansas forMedical Sciences (UAMS) and Arkansas Children's Hospital. He is also the medical director for the Allergy and Eosinophilic Gastrointestinal Disorders Clinics at ACH. Dr. Pesek received his Bachelor of Science from the University of Arkansas at Fayetteville and completed his medical degree at UAMS. He completed his Pediatric residency at ACH and training in Allergy/Immunology at the University of South Florida in Tampa, Florida. He joined the faculty at ACH in 2011. Dr. Pesek is a member of the Arkansas Medical Society, American Academy of Pediatrics, American College of Allergy, Asthma, and Immunology, and the American Academy of Allergy, Asthma, and Immunology. His current research interests include primary immunodeficiency, food allergies, and eosinophilic gastrointestinal disorders. Some of the UAMS College of Medicine faculty members provide pediatric patient care at Arkansas Children's Hospital. In addition, a wide range of pediatric services are provided in more than 35 subspecialties around Arkansas in locations such as the Schmieding Developmental Center in Springdale and the James L. Dennis Developmental Center in Little Rock. To make an appointment at Arkansas Children's Hospital, please call 501-364-4000.

Metrics

h-index: 19
Publications: 68
Citations: 1,277

Selected Publications

Patient-Reported Outcome Scores Are Comparable in Multiregional Versus Uniregional Eosinophilic Esophagitis (2025) DOI
Current Practices Among 13 Severe Pediatric Asthma Programs in the United States (2025) DOI
Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis (2025) DOI
Video directly observed therapy to improve inhaler technique among pediatric patients with persistent asthma (2025) DOI
Rare inborn error of immunity presenting as acute respiratory failure (2024) DOI
S661 Dupilumab Improves Multiple Histopathologic Endpoints in Children With Eosinophilic Esophagitis: 52-Week Results From the Phase 3 EoE KIDS Trial (2024) DOI
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections (2024) DOI
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting (2024) DOI
Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis (2024) DOI
A Rare Condition Masquerading as a Common Disease (2024) DOI
Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial (2024) DOI
Food insecurity and allergic diseases: A call to collective action (2023) DOI
Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting (2023) DOI
Implementation of a Respiratory Therapist–Driven Protocol for Spirometry and Asthma Education in a Pediatric Out-Patient Primary Care Setting (2023) DOI
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy (2023) DOI